Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.

Holczbauer Á, Gyöngyösi B, Lotz G, Szijártó A, Kupcsulik P, Schaff Z, Kiss A.

J Histochem Cytochem. 2013 Apr;61(4):294-305. doi: 10.1369/0022155413479123. Epub 2013 Feb 5.

2.

Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.

Somorácz A, Tátrai P, Horváth G, Kiss A, Kupcsulik P, Kovalszky I, Schaff Z.

Hum Pathol. 2010 Sep;41(9):1310-9. doi: 10.1016/j.humpath.2009.10.029. Epub 2010 May 14.

PMID:
20471664
3.

Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.

Lódi C, Szabó E, Holczbauer A, Batmunkh E, Szíjártó A, Kupcsulik P, Kovalszky I, Paku S, Illyés G, Kiss A, Schaff Z.

Mod Pathol. 2006 Mar;19(3):460-9.

4.

Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.

Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D, Scopa CD, Tsamandas AC.

In Vivo. 2014 May-Jun;28(3):315-26.

PMID:
24815833
6.

Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.

Rubie C, Frick VO, Wagner M, Weber C, Kruse B, Kempf K, König J, Rau B, Schilling M.

World J Gastroenterol. 2006 Nov 7;12(41):6627-33.

7.

KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.

Guo XZ, Friess H, Di Mola FF, Heinicke JM, Abou-Shady M, Graber HU, Baer HU, Zimmermann A, Korc M, Büchler MW.

Hepatology. 1998 Dec;28(6):1481-8.

PMID:
9828210
8.

Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas.

Kanai M, Hamada J, Takada M, Asano T, Murakawa K, Takahashi Y, Murai T, Tada M, Miyamoto M, Kondo S, Moriuchi T.

Oncol Rep. 2010 Mar;23(3):843-51.

PMID:
20127028
9.

Claudin-7 expression in hepatocellular carcinoma.

Brokalaki EI, Weber F, Sotiropoulos GC, Daoudaki M, Cicinnati VR, Beckebaum S.

Transplant Proc. 2012 Nov;44(9):2737-40. doi: 10.1016/j.transproceed.2012.09.009.

PMID:
23146509
10.

Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.

Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):551-6.

11.

Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.

Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y.

Am J Pathol. 2003 Jun;162(6):1961-74.

12.

Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.

Patonai A, Erdélyi-Belle B, Korompay A, Somorácz A, Straub BK, Schirmacher P, Kovalszky I, Lotz G, Kiss A, Schaff Z.

Virchows Arch. 2011 Jun;458(6):679-88. doi: 10.1007/s00428-011-1077-y. Epub 2011 Apr 19.

PMID:
21503766
13.

Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.

Sobel G, Németh J, Kiss A, Lotz G, Szabó I, Udvarhelyi N, Schaff Z, Páska C.

Gynecol Oncol. 2006 Nov;103(2):591-8. Epub 2006 Jun 22.

PMID:
16797678
14.

Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas.

Jung JH, Jung CK, Choi HJ, Jun KH, Yoo J, Kang SJ, Lee KY.

Pathol Res Pract. 2009;205(6):409-16. doi: 10.1016/j.prp.2008.12.015. Epub 2009 Feb 20.

PMID:
19231096
15.

Increased expression of claudin-1 and claudin-7 in liver cirrhosis and hepatocellular carcinoma.

Holczbauer Á, Gyöngyösi B, Lotz G, Törzsök P, Kaposi-Novák P, Szijártó A, Tátrai P, Kupcsulik P, Schaff Z, Kiss A.

Pathol Oncol Res. 2014 Jul;20(3):493-502. doi: 10.1007/s12253-013-9683-4. Epub 2014 Apr 3.

PMID:
24696415
16.

Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.

Ikeguchi M, Hirooka Y, Kaibara N.

Cancer. 2002 Nov 1;95(9):1938-45.

17.

Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling.

Tackels-Horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, Vogt LM, Boland JF, Scherf U, Vockley JG.

Cancer. 2001 Jul 15;92(2):395-405.

PMID:
11466695
18.

The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.

St Hill CA, Farooqui M, Mitcheltree G, Gulbahce HE, Jessurun J, Cao Q, Walcheck B.

BMC Cancer. 2009 Mar 6;9:79. doi: 10.1186/1471-2407-9-79.

19.

Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer.

Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T.

Oncol Rep. 2008 Apr;19(4):953-9.

PMID:
18357381
20.

[WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].

Zhu B, Cong W, Wang H.

Zhonghua Gan Zang Bing Za Zhi. 1999 Dec;7(4):217-20. Chinese.

PMID:
10715791

Supplemental Content

Support Center